| Literature DB >> 16445510 |
Joachim Dissemond1, Daniela Hoeft, Julia Knab, Tom Franckson, Knut Kroger, Manfred Goos.
Abstract
Hydroxyurea is a hydroxylated derivate of urea commonly used in the treatment of various hematologic disorders. Cutaneous side-effects such as alopecia, diffuse hyperpigmentation, scaling, poikiloderma, atrophy of the skin and subcutaneous tissues or nail changes can develop after long-term treatment with hydroxyurea. Painful leg ulcers in association with hydroxyurea have only rarely been reported. We present a report of a 52-year-old patient with essential thrombocythemia suffering from painful leg ulcers 3 years after starting therapy with hydroxyurea. We decided to treat the leg ulcers following a modern phase-adapted wound-healing strategy and continued hydroxyurea therapy until complete healing of the ulcers. In conclusion, cutaneous ulceration of the leg is one adverse effect in patients with essential thrombocythemia during hydroxyurea therapy. Healing does not necessarily require discontinuation of the drug. Therefore, therapists should first optimize a conservative and systematic wound-healing strategy. If these interventions fail, discontinuation of hydroxyurea therapy is advisable.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16445510 DOI: 10.1111/j.1365-4632.2004.02450.x
Source DB: PubMed Journal: Int J Dermatol ISSN: 0011-9059 Impact factor: 2.736